Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3042% above fair value
$279.25−4.60 (-1.62%)
Close on Nov 17, 2026Market cap $64.95BP/E 38.6Yield 0.73%
Cardinal Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cardinal Health's operating cash flow for the twelve months ending Jun 30, 2026 was $5.17B, up 115.9% year over year. For fiscal 2026 it was $5.17B, up 115.9% from the year before. Over ten years it grew 5.7% a year on average. The highest annual figure on record is $5.17B in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $5.17B | +115.9% |
| FY2025 | Jun 30, 2025 | $2.40B | -36.3% |
| FY2024 | Jun 30, 2024 | $3.76B | +32.3% |
| FY2023 | Jun 30, 2023 | $2.84B | -10.4% |
| FY2022 | Jun 30, 2022 | $3.18B | +30.7% |
| FY2021 | Jun 30, 2021 | $2.43B | +23.9% |
| FY2020 | Jun 30, 2020 | $1.96B | -28.0% |
| FY2019 | Jun 30, 2019 | $2.72B | -1.7% |
| FY2018 | Jun 30, 2018 | $2.77B | +133.8% |
| FY2017 | Jun 30, 2017 | $1.18B | -60.1% |
| FY2016 | Jun 30, 2016 | $2.97B | +17.0% |
| FY2015 | Jun 30, 2015 | $2.54B | +0.6% |
| FY2014 | Jun 30, 2014 | $2.52B | +46.1% |
| FY2013 | Jun 30, 2013 | $1.73B | +46.9% |
| FY2012 | Jun 30, 2012 | $1.18B | -15.7% |
| FY2011 | Jun 30, 2011 | $1.40B | -34.6% |
| FY2010 | Jun 30, 2010 | $2.13B | +49.9% |
| FY2009 | Jun 30, 2009 | $1.42B | -7.6% |
| FY2008 | Jun 30, 2008 | $1.54B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $1.69B | +11.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $1.82B | -37.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $686.00M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $973.00M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.52B | -27.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.92B | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$396.00M | -133.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$1.65B | -411.9% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $2.08B | +141.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$27.00M | -102.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $1.18B | +97.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $528.00M | +2195.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $863.00M | -71.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $1.36B | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $597.00M | -50.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $23.00M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $3.05B | +357.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$419.00M | -251.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.20B | -1.8% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$646.00M | -339.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $665.00M | +177.1% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $277.00M | -83.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.22B | +74.6% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $270.00M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $240.00M | -52.6% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.68B | +13.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $697.00M | +87.9% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$653.00M | -278.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $506.00M | -8.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.48B | +96.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $371.00M | +33.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $365.00M | -69.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $554.00M | -23.5% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $754.00M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $279.00M | -49.6% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.18B | +1035.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $724.00M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$198.00M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $554.00M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $104.00M | – |
See a number that looks wrong?